Back to search
Amyloidogenic Transthyretin (ATTR) Amyloidosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Amyloidogenic Transthyretin (ATTR) Amyloidosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Amyloidogenic Transthyretin (ATTR) Amyloidosis trials you may qualify forThe goal of this study is to learn whether PET-CT imaging using evuzamitide can help diagnose transthyretin cardiac amyloidosis (ATTR-CA) in patients whose stan…
The AG10-504 study is an open-label extension study of acoramidis in participants with newly diagnosed transthyretin amyloid cardiomyopathy (ATTR-CM) or both AT…
A Phase 1, open-label study of intravenous (IV) PRX004 as a single agent in subjects with hereditary amyloid transthyretin (hATTR) amyloidosis. The study will c…